Market Tracker

09/27 5:16pm ET

Celldex Therapeutics Inc (NASDAQ:CLDX)

4.23
Delayed Data
As of 3:59pm ET
 +0.43 / +11.32%
Today’s Change
2.96
Today|||52-Week Range
18.62
-73.02%
Year-to-Date
Why Celldex Therapeutics, Inc. Ran Higher Today
4:26pm / MotleyFool.com - Paid Partner Content
3 Stocks That Could Make You Rich
Sep 26 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close3.80
Today’s open3.80
Day’s range3.78 - 4.24
Volume4,900,550
Average volume (3 months)2,328,189
Market cap$382.1M
Dividend yield--
Data as of 3:59pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)+0.76%
Earnings growth (this year)-2.10%
Earnings growth (next 5 years)--
Revenue growth (last year)+52.82%
P/E ratioNM
Price/Sales277.69
Price/Book1.29

Competitors

 Today’s
change
Today’s
% change
TRIBTrinity Biotech PLC-0.03-0.23%
IMMUImmunomedics Inc+0.14+4.29%
LNTHLantheus Holdings In...+0.01+0.12%
OXFDOxford Immunotec Glo...+0.19+1.57%
Data as of 3:59pm ET, 09/27/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$5.5M
Annual profit (last year)-$127.2M
Net profit margin-2,321.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
CFO, Secretary, Treasurer &
Senior Vice President
Avery W. Catlin
Corporate headquarters
Hampton, New Jersey

Forecasts